| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c96d2c5bffe3b7db09a203798e102f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ae1c9b83f72f99c4f7019a8c1c6d98b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1fe44f461e6276c6b042f4826c7ad87 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2005-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c3d9fecb4dfa0a422b465b49c8d790
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd2ac300ad4b848419c1b57c1deb33ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c03a75e9ce1a7b7abdb1d6004b652720 |
| publicationDate |
2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007258969-A1 |
| titleOfInvention |
Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers |
| abstract |
Disclosed herein are compositions comprising a drug linked to a multivalent ligand polysaccharide and the use of this composition in the prevention and treatment of cancer. In one aspect, the polysaccharide is obtained by physical and chemical treatment of naturally occurring polymers or semi synthetic polymers which are bridged specifically with one or more anti-cancer chemotherapeutic agents. Another aspect is directed to the effective delivery of the polysaccharide together with the chemotherapeutic agent to diseased tissue including cancerous tissue. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008207516-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8828971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014059135-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2462471-C1 |
| priorityDate |
2004-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |